Result of General Meeting

AI SummaryClose X

Roquefort Therapeutics plc announced that all resolutions were passed at its General Meeting, facilitating the completion of its acquisition of AO-252 from Coiled Therapeutics, Inc., and a £8.5 million fundraise. The company's listing on the Main Market will be cancelled, and its shares will be admitted to trading on AIM under the new name Coiled Therapeutics plc, with 425,856,539 new ordinary shares expected to trade from 8:00 a.m. tomorrow, March 27, 2026. Directors participated in the fundraise, with Dr. Sotirios Stergiopoulos investing £500,000, Sridhar Vempati investing £500,000, and Stephen West investing £50,000.

Disclaimer*

UK 100

Latest directors dealings